Lamanna, N., Tam, C. S., Woyach, J. A., Alencar, A. J., Palomba, M. L., Zinzani, P. L., Flinn, I. W., Fakhri, B., Cohen, J. B., Kontos, A., Konig, H., Ruppert, A. S., Chatterjee, A., Sizelove, R., Compte, L., Tsai, D. E., & Jurczak, W. (2024). Evaluation of bleeding risk in patients who received pirtobrutinib in the presence or absence of antithrombotic therapy. EJHaem, 5(5), 929–939. Portico. https://doi.org/10.1002/jha2.1013

SahBandar, I. N., Maegawa, G. H. B., Brandman, D., Rand, J. H., Lim, H. I., & Geyer, J. T. (2024). A diagnosis of non‐neuronopathic and late‐onset acid sphingomyelinase deficiency (Niemann‐Pick disease A/B) following bone marrow biopsy showing foamy histiocytosis. EJHaem, 5(5), 1078–1079. Portico. https://doi.org/10.1002/jha2.1003

Pemmaraju, N., Cuglievan, B., Lasky, J., Kheradpour, A., Hijiya, N., Stein, A. S., Meshinchi, S., Mullen, C. A., Angelucci, E., Vinti, L., Mughal, T. I., & Pawlowska, A. B. (2024). Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients. EJHaem, 5(1), 61–69. Portico. https://doi.org/10.1002/jha2.856

Filgueira, L., Steinberg, A., Mendonca, R., & Lim, S. H. (2023). Returning to employment following allogeneic hematopoietic stem cell transplant: A major problem among survivors. EJHaem, 4(4), 1132–1142. Portico. https://doi.org/10.1002/jha2.788

Rosenthal, A., Duvall, A., Kahn, J., & Khan, N. (2023). Disparities in care and outcomes for adolescent and young adult lymphoma patients. EJHaem, 4(4), 934–939. Portico. https://doi.org/10.1002/jha2.797

Ali, M. O., Abdullah, H. M., Obeidat, K., Chakraborty, R., & Al Hadidi, S. (2023). Follow up duration of phase III Multiple Myeloma Clinical Trials: A systematic review. EJHaem, 4(3), 719–722. Portico. https://doi.org/10.1002/jha2.680

Baljevic, M., Gasparetto, C., Schiller, G. J., Tuchman, S. A., Callander, N. S., Lentzsch, S., Monge, J., Kotb, R., Bahlis, N. J., White, D., Chen, C. I., Sutherland, H. J., Madan, S., LeBlanc, R., Sebag, M., Venner, C. P., Bensinger, W. I., Biran, N., DeCastro, A., … Lipe, B. (2022). Selinexor‐based regimens in patients with multiple myeloma after prior anti‐B‐cell maturation antigen treatment. EJHaem, 3(4), 1270–1276. Portico. https://doi.org/10.1002/jha2.572